middle.news
Lumos Expands Medicare Coverage for FebriDx to Six US Regions
1:37am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Lumos Expands Medicare Coverage for FebriDx to Six US Regions
1:37am on Monday 2nd of June, 2025 AEST
Key Points
Medicare reimbursement secured from sixth MAC, CGS Administrators
Coverage now spans over 85% of US Medicare payment regions
Reimbursement rate set at US$41.38 per FebriDx test
Only one MAC remains to be secured for full Medicare coverage
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics Holdings (ASX:LDX)
OPEN ARTICLE